Activated cyclin-dependent kinase 5 promotes microglial phagocytosis of fibrillar β-amyloid by up-regulating lipoprotein lipase expression

Molecular and Cellular Proteomics

Volumn 12, Issue 10, 2013, Pages 2833-2844

  Ma, Yuanhui ^a   Bao, Jintao ^a   Zhao, Xuyang ^a   Shen, Hongyan ^a   Lv, Junniao ^a   Ma, Shuaipeng ^a   Zhang, Xuefei ^a   Li, Zeyang ^a   Wang, Shuxin ^a   Wang, Qingsong ^a   Ji, Jianguo ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; CYCLIN DEPENDENT KINASE 5; LIPOPROTEIN LIPASE; MESSENGER RNA; PROTEIN P25; PROTEIN P35;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CELL PHAGOCYTOSIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE SILENCING; INTERNALIZATION; ISOTOPE LABELING; LYSOSOME; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

AMYLOID BETA-PEPTIDES; ANIMALS; CELL LINE; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 5; LIPOPROTEIN LIPASE; MICE; MICROGLIA; PHAGOCYTOSIS; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 84885171213     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M112.026864     Document Type: Article

References (59)

1. Sultana, R., and Butterfield, D. A. (2010) Role of oxidative stress in the progression of Alzheimer's disease. J. Alzheimers Dis. 19, 341-353
2. Cruz, J. C, Kim, D., Moy, L. Y., Dobbin, M. M., Sun, X., Bronson, R. T., and Tsai, L. H. (2006) p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo. J. Neurosci. 26, 10536-10541
3. Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., and Tsai, L. H. (1999) Conversion of p35to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622
4. Avila, J., Wandosell, F., and Hernandez, F. (2010) Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors. Expert Rev. Neurother. 10, 703-710
5. Amor, S., Puentes, F., Baker, D., and van der Valk, P. (2010) Inflammation in neurodegenerative diseases. Immunology 129, 154-169
6. Paresce, D. M., Ghosh, R. N., and Maxfield, F. R. (1996) Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 17, 553-565
7. Husemann, J., Loike, J. D., Kodama, T., and Silverstein, S. C. (2001) Scavenger receptor class B type I (SR-BI) mediates adhesion of neonatal murine microglia to fibrillar beta-amyloid. J. Neuroimmunol. 114, 142-150
8. Liu, Y., Walter, S., Stagi, M., Cherny, D., Letiembre, M., Schulz-Schaeffer, W., Heine, H., Penke, B., Neumann, H., and Fassbender, K. (2005) LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. Brain 128, 1778-1789
9. Griciuc, A., Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. H., Hyman, B. T., and Tanzi, R. E. (2013) Alzheimer's Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta. Neuron 78, 631-643
10. Kunjathoor, V. V., Tseng, A. A., Medeiros, L. A., Khan, T., and Moore, K. J. (2004) beta-Amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteins. J. Neuroinflammation 1, 23
11. Miller, T. W., Isenberg, J. S., Shih, H. B., Wang, Y., and Roberts, D. D. (2010) Amyloid-beta inhibits No-cGMP signaling in a CD36-and CD47-dependent manner. PLoS One 5, e15686
12. Koenigsknecht, J., and Landreth, G. (2004) Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism. J. Neurosci. 24, 9838-9846
13. Chen, K., Iribarren, P., Hu, J., Chen, J., Gong, W., Cho, E. H., Lockett, S., Dunlop, N. M., and Wang, J. M. (2006) Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. J. Biol. Chem. 281, 3651-3659
14. Song, M., Jin, J., Lim, J. E., Kou, J., Pattanayak, A., Rehman, J. A., Kim, H. D., Tahara, K., Lalonde, R., and Fukuchi, K. (2011) TLR4 mutation reduces microglial activation, increases Abeta deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease. J. Neuroinflammation 8, 92
15. Koenigsknecht-Talboo, J., and Landreth, G. E. (2005) Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J. Neurosci. 25, 8240-8249
16. Liu, Z., Condello, C, Schain, A., Harb, R., and Grutzendler, J. (2010) CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-beta phagocytosis. J. Neurosci. 30, 17091-17101
17. Farfara, D., Trudler, D., Segev-Amzaleg, N., Galron, R., Stein, R., and Frenkel, D. (2011) gamma-Secretase component presenilin is important for microglia beta-amyloid clearance. Ann. Neurol. 69, 170-180
18. Lee, C. Y., Tse, W., Smith, J. D., and Landreth, G. E. (2012) Apolipoprotein E promotes beta-amyloid trafficking and degradation by modulating microglial cholesterol levels. J. Biol. Chem. 287, 2032-2044
19. Majumdar, A., Capetillo-Zarate, E., Cruz, D., Gouras, G. K., and Maxfield, F. R. (2011) Degradation of Alzheimer's amyloid fibrils by microglia requires delivery of ClC-7 to lysosomes. Mol. Biol. Cell 22, 1664-1676
20. Majumdar, A., Cruz, D., Asamoah, N., Buxbaum, A., Sohar, I., Lobel, P., and Maxfield, F. R. (2007) Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils. Mol. Biol. Cell 18, 1490-1496
21. Ong, S. E., and Mann, M. (2006) A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat. Protoc. 1, 2650-2660
22. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., and Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386
23. McDonald, D. R., Brunden, K. R., and Landreth, G. E. (1997) Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J. Neurosci. 17, 2284-2294
24. Saura, J., Tusell, J. M., and Serratosa, J. (2003) High-yield isolation of murine microglia by mild trypsinization. Glia 44, 183-189
25. Wisniewski, J. R., Zougman, A., Nagaraj, N., and Mann, M. (2009) Universal sample preparation method for proteome analysis. Nat. Methods 6, 359-362
26. Thingholm, T. E., Jørgensen, T. J., Jensen, O. N., and Larsen, M. R. (2006) Highly selective enrichment of phosphorylated peptides using titanium dioxide. Nat Protoc 1, 1929-1935
27. Cox, J., and Mann, M. (2008) MaxQuant enables high peptide identification rates, individualized p. p. b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372
28. Cox, J., Matic, I., Hilger, M., Nagaraj, N., Selbach, M., Olsen, J. V., and Mann, M. (2009) A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics. Nat. Protoc. 4, 698-705
29. Nogales-Cadenas, R., Carmona-Saez, P., Vazquez, M., Vicente, C., Yang, X., Tirado, F., Carazo, J. M., and Pascual-Montano, A. (2009) GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Res. 37, W317-W322
30. Tabas-Madrid, D., Nogales-Cadenas, R., and Pascual-Montano, A. (2012) GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res. 40, W478-W483
31. Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., and Golenbock, D. T. (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9, 857-865
32. Liu, J., Hong, Z., Ding, J., Liu, J., Zhang, J., and Chen, S. (2008) Predominant release of lysosomal enzymes by newborn rat microglia after LPS treatment revealed by proteomic studies. J. Proteome Res. 7, 2033-2049
33. Kota, B. P., Huang, T. H., and Roufogalis, B. D. (2005) An overview on biological mechanisms of PPARs. Pharmacol. Res. 51, 85-94
34. Mulder, M., Lombardi, P., Jansen, H., van Berkel, T. J., Frants, R. R., and Havekes, L. M. (1993) Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase. J. Biol. Chem. 268, 9369-9375
35. Williams, K. J., Fless, G. M., Petrie, K. A., Snyder, M. L., Brocia, R. W., and Swenson, T. L. (1992) Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein (a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. J. Biol. Chem. 267, 13284-13292
36. Lee, M. S., Kwon, Y. T., Li, M., Peng, J., Friedlander, R. M., and Tsai, L. H. (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360-364
37. Lim, A. C., Qu, D., and Qi, R. Z. (2003) Protein-protein interactions in Cdk5 regulation and function. Neurosignals 12, 230-238
38. Tsai, L. H., Delalle, I., Caviness, V. S., Jr., Chae, T., and Harlow, E. (1994) p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371, 419-423
39. Mandrekar-Colucci, S., and Landreth, G. E. (2010) Microglia and inflammation in Alzheimer's disease. CNS Neurol. Disord. Drug Targets 9, 156-167
40. Rivest, S. (2009) Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 9, 429-439
41. Streit, W. J., Mrak, R. E., and Griffin, W. S. (2004) Microglia and neuroinflammation: a pathological perspective. J. Neuroinflammation 1, 14
42. Poole, E., Groves, I., MacDonald, A., Pang, Y., Alcami, A., and Sinclair, J. (2009) Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus. J. Virol. 83, 3581-3590
43. Boukerche, H., Aissaoui, H., Prévost, C., Hirbec, H., Das, S. K., Su, Z. Z., Sarkar, D., and Fisher, P. B. (2010) Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB. Oncogene 29, 3054-3066
44. Kim, J., Basak, J. M., and Holtzman, D. M. (2009) The role of apolipoprotein E in Alzheimer's disease. Neuron 63, 287-303
45. Jiang, Q., Lee, C. Y., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T. M., Collins, J. L., Richardson, J. C., Smith, J. D., Comery, T. A., Riddell, D., Holtzman, D. M., Tontonoz, P., and Landreth, G. E. (2008) ApoE promotes the proteolytic degradation of Abeta. Neuron 58, 681-693
46. Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., Higgs, R., Liu, F., Malkani, S., Bales, K. R., and Paul, S. M. (2004) Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat. Med. 10, 719-726
47. Nishitsuji, K., Hosono, T., Uchimura, K., and Michikawa, M. (2011) Lipoprotein lipase is a novel amyloid beta (Abeta)-binding protein that promotes glycosaminoglycan-dependent cellular uptake of Abeta in astrocytes. J. Biol. Chem. 286, 6393-6401
48. Baum, L., Chen, L., Masliah, E., Chan, Y. S., Ng, H. K., and Pang, C. P. (1999) Lipoprotein lipase mutations and Alzheimer's disease. Am. J. Med. Genet. 88, 136-139
49. Ben-Zeev, O., Doolittle, M. H., Singh, N., Chang, C. H., and Schotz, M. C. (1990) Synthesis and regulation of lipoprotein lipase in the hippocampus. J. Lipid Res. 31, 1307-1313
50. Blain, J. F., Aumont, N., Théroux, L., Dea, D., and Poirier, J. (2006) A polymorphism in lipoprotein lipase affects the severity of Alzheimer's disease pathophysiology. Eur. J. Neurosci. 24, 1245-1251
51. Wolozin, B. (2001) A fluid connection: cholesterol and Abeta. Proc. Natl. Acad. Sci. U. S. A. 98, 5371-5373
52. Schoonjans, K., Peinado-Onsurbe, J., Fruchart, J. C., Tailleux, A., Fiévet, C., and Auwerx, J. (1999) 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase. FEBS Lett. 452, 160-164
53. Gupta, A., Tsai, L. H., and Wynshaw-Boris, A. (2002) Life is a journey: a genetic look at neocortical development. Nat. Rev. Genet. 3, 342-355
54. Meuer, K., Suppanz, I. E., Lingor, P., Planchamp, V., Göricke, B., Fichtner, L., Braus, G. H., Dietz, G. P., Jakobs, S., Bähr, M., and Weishaupt, J. H. (2007) Cyclin-dependent kinase 5 is an upstream regulator of mitochondrial fission during neuronal apoptosis. Cell Death Differ. 14, 651-661
55. Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., and Tsai, L. H. (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622
56. Muyllaert, D., Terwel, D., Kremer, A., Sennvik, K., Borghgraef, P., Devijver, H., Dewachter, I., and Van Leuven, F. (2008) Neurodegeneration and Neuroinflammation in cdk5/p25-Inducible Mice: A Model for Hippocampal Sclerosis and Neocortical Degeneration. Am. J. Pathol. 172, 470-485
57. Rodriguez, J. J., Witton, J., Olabarria, M., Noristani, H. N., and Verkhratsky, A. (2010) Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer's disease. Cell Death Dis. 1, e1
58. Frautschy, S. A., Yang, F., Irrizarry, M., Hyman, B., Saido, T. C., Hsiao, K., and Cole, G. M. (1998) Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 152, 307-317
59. Qiu, W. Q., Walsh, D. M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M. B., Rosner, M. R., Safavi, A., Hersh, L. B., and Selkoe, D. J. (1998) Insulindegrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J. Biol. Chem. 273, 32730-32738